Park Avenue Securities’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
CCA
KF
AWM
KAS
ASN
Park Avenue Securities's BTAL Position: Q4 2025 in Review
Park Avenue Securities sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 27,869 shares — an estimated $444K sold.
Park Avenue Securities first reported a position in BTAL in Q3 2025 and held it in 1 quarter. The position peaked at $444K in Q3 2025. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.
- Park Avenue Securities reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
- Park Avenue Securities sold 27,869 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $444K.
- Park Avenue Securities first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2025 and held it in 1 quarter.
- Park Avenue Securities's AGF US Market Neutral Anti-Beta Fund position peaked at $444K in Q3 2025.
- 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.
Based on Park Avenue Securities's 13F filing for Q4 2025, filed 5 Jan 2026.